FR2408580A1 - Compositions de polypeptides contenant la sequence l-arginine-l-lysine-(acide l-aspartique)-l-valine-l-tyrosine, leur procede d'obtention et compositions therapeutiques en comportant - Google Patents
Compositions de polypeptides contenant la sequence l-arginine-l-lysine-(acide l-aspartique)-l-valine-l-tyrosine, leur procede d'obtention et compositions therapeutiques en comportantInfo
- Publication number
- FR2408580A1 FR2408580A1 FR7804597A FR7804597A FR2408580A1 FR 2408580 A1 FR2408580 A1 FR 2408580A1 FR 7804597 A FR7804597 A FR 7804597A FR 7804597 A FR7804597 A FR 7804597A FR 2408580 A1 FR2408580 A1 FR 2408580A1
- Authority
- FR
- France
- Prior art keywords
- compositions
- valine
- arginine
- lysine
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/66—Thymopoietins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'INVENTION CONCERNE DES POLYPEPTIDES, LEUR OBTENTION ET DES COMPOSITIONS THERAPEUTIQUES QUI EN CONTIENNENT. CES COMPOSITIONS CONTIENNENT COMME SITE ACTIF LA SEQUENCE DES AMINO-ACIDES SUIVANTS:ARG-LYS-ASP-VAL-TYRCE POLYPEPTIDE PEUT INDUIRE LA DIFFERENCIATION DES LYMPHOCYTES DU THYMUS (T) MAIS NON CELLES DES LYMPHOCYTES B (DE MOELLE DES OS) COMPORTANT DES RECEPTEURS DE COMPLEMENT. LE POLYPEPTIDE PEUT NOTAMMENT SERVIR A CORRIGER DES DEFICIENCES RELATIVES OU ABSOLUES DU THYMUS OU A TRAITER DES ETATS RESULTANT D'UN EXCES D'ACTIVITE NEUROMUSCULAIRE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85177777A | 1977-11-15 | 1977-11-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2408580A1 true FR2408580A1 (fr) | 1979-06-08 |
FR2408580B1 FR2408580B1 (fr) | 1983-01-07 |
Family
ID=25311654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7804597A Granted FR2408580A1 (fr) | 1977-11-15 | 1978-02-17 | Compositions de polypeptides contenant la sequence l-arginine-l-lysine-(acide l-aspartique)-l-valine-l-tyrosine, leur procede d'obtention et compositions therapeutiques en comportant |
Country Status (7)
Country | Link |
---|---|
JP (2) | JPS5476543A (fr) |
BE (1) | BE864121A (fr) |
CA (1) | CA1105925A (fr) |
CH (1) | CH639941A5 (fr) |
DE (1) | DE2804566C2 (fr) |
FR (1) | FR2408580A1 (fr) |
SE (1) | SE446867B (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0025897A2 (fr) * | 1979-09-22 | 1981-04-01 | Hoechst Aktiengesellschaft | Peptides et procédé pour leur préparation |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215112A (en) * | 1979-03-14 | 1980-07-29 | Ortho Pharmaceutical Corporation | Tripeptides and methods |
US4215111A (en) * | 1979-03-14 | 1980-07-29 | Ortho Pharmaceutical Corporation | Peptides having ubiquitin-like activity |
JPS55149237A (en) * | 1979-04-12 | 1980-11-20 | Ortho Pharma Corp | Thymopoietin active peptide |
US4426324A (en) * | 1979-09-28 | 1984-01-17 | Hoffmann-La Roche Inc. | Immunopotentiating peptides |
US4298523A (en) * | 1980-06-17 | 1981-11-03 | Ortho Pharmaceutical Corporation | Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R |
DE3401545A1 (de) * | 1983-08-03 | 1985-02-14 | Hoechst Ag, 6230 Frankfurt | Neue peptide mit immunstimulierender wirkung, verfahren zu deren herstellung und deren verwendung |
US4629723A (en) * | 1984-06-27 | 1986-12-16 | Ortho Pharmaceutical Corporation | Potent thymopentin analogs |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4002740A (en) * | 1975-08-21 | 1977-01-11 | Gideon Goldstein | Tridecapeptide compositions and methods |
-
1978
- 1978-01-27 SE SE7801030A patent/SE446867B/sv not_active IP Right Cessation
- 1978-02-03 DE DE2804566A patent/DE2804566C2/de not_active Expired
- 1978-02-08 CA CA296,490A patent/CA1105925A/fr not_active Expired
- 1978-02-17 FR FR7804597A patent/FR2408580A1/fr active Granted
- 1978-02-20 BE BE185306A patent/BE864121A/fr not_active IP Right Cessation
- 1978-02-22 JP JP1956778A patent/JPS5476543A/ja active Granted
- 1978-02-24 CH CH206278A patent/CH639941A5/de not_active IP Right Cessation
-
1985
- 1985-05-22 JP JP60111320A patent/JPS6150998A/ja active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4002740A (en) * | 1975-08-21 | 1977-01-11 | Gideon Goldstein | Tridecapeptide compositions and methods |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0025897A2 (fr) * | 1979-09-22 | 1981-04-01 | Hoechst Aktiengesellschaft | Peptides et procédé pour leur préparation |
EP0025897A3 (en) * | 1979-09-22 | 1981-07-01 | Hoechst Aktiengesellschaft | Peptides and process for their preparation |
Also Published As
Publication number | Publication date |
---|---|
BE864121A (fr) | 1978-08-21 |
CH639941A5 (en) | 1983-12-15 |
SE446867B (sv) | 1986-10-13 |
JPS5476543A (en) | 1979-06-19 |
DE2804566A1 (de) | 1979-05-17 |
JPS6118560B2 (fr) | 1986-05-13 |
CA1105925A (fr) | 1981-07-28 |
DE2804566C2 (de) | 1986-01-16 |
JPH0137399B2 (fr) | 1989-08-07 |
SE7801030L (sv) | 1979-05-16 |
JPS6150998A (ja) | 1986-03-13 |
FR2408580B1 (fr) | 1983-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4079127A (en) | Thymosin alpha 1 | |
OA06421A (fr) | Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides. | |
Bird et al. | Identification of a common class of high affinity receptors for both types of porcine interleukin-1 on connective tissue cells | |
US3926938A (en) | Synthesis of salmon calcitonin | |
BG60256B1 (bg) | Рекомбинантен метод за получаване на лимфотоксин | |
DK614987D0 (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
NO932148L (no) | Fusjonspolypeptider | |
FR2408580A1 (fr) | Compositions de polypeptides contenant la sequence l-arginine-l-lysine-(acide l-aspartique)-l-valine-l-tyrosine, leur procede d'obtention et compositions therapeutiques en comportant | |
DE3064559D1 (en) | Tripeptides, process for their preparation, therapeutic compositions containing them and methods for their use | |
RU94023251A (ru) | Способ получения гидрофобных полипептидов, протеинов или пептидов | |
NO900758L (no) | Fremgangsmaate for fremstilling av hybridprotein. | |
FR2408581A1 (fr) | Composition de pentapeptide, son procede d'obtention et composition therapeutique en comportant | |
Kato et al. | Purification and partial sequence analysis of human interleukin-2 derived from peripheral blood leukocytes | |
Wolfenstein-Todel et al. | Immunoglobulin A. Arrangement of disulfide bridges in the hinge region of an immunoglobulin A1 human myeloma protein | |
Trischmann et al. | Primary structure of the CH3 homology region from guinea pig IgG2 antibodies | |
DK0426314T3 (da) | HIV-relaterede peptider | |
THURMAN et al. | Thymosin al: Isolation and sequence analysis of an immunologically active thymic polypeptide | |
Sulkowski et al. | Crystalline basic protein from venom of Crotalus adamanteus | |
Sundar-Raj et al. | Structure and biosynthesis of rabbit lens capsule collagen. | |
SU1149603A1 (ru) | Полипептид,обладающий гипогликемической активностью | |
ATE4196T1 (de) | Ovulation stimulierende peptide und deren pharmazeutische zusammensetzungen. | |
ES474904A1 (es) | Un procedimiento para la preparacion de un tripeptido | |
JPH0749439B2 (ja) | サイトカイン誘導性好中球誘因蛋白質 |